Article

Measurable Residual<i>IDH1</i>before Allogeneic Transplant for Acute Myeloid Leukemia

2023-08-01

Abstract excerpt

Measurable residual disease (MRD) in adults with acute myeloid leukemia (AML) in complete remission is an important prognostic marker, but detection methodology requires optimization. The persistence of mutated NPM1 or FLT3 -ITD in the blood of adult patients with AML in first complete remission (CR1) prior to allogeneic hematopoetic cell transplant (alloHCT) has been established as associated with increased relap...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 70e51505-7ec1-5f75-acdb-f9dc967a0972
DOI: 10.1101/2023.07.28.23293166

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Measurable Residual<i>IDH1</i>before Allogeneic Transplant for Acute Myeloid LeukemiaDOI 10.1101/2023.07.28.23293166Read

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.Semantic proximity Read

Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia.Semantic proximity Read

Pre-MEASURE:<i>FLT3</i>-ITD and mutated<i>NPM1</i>measurable residual disease before allogeneic transplant in adults with AML in first remissionSemantic proximity Read

Persistent<i>IDH</i>mutations are not associated with increased relapse or death in patients with<i>IDH</i>-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideSemantic proximity Read

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaSemantic proximity Read

Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemiaSemantic proximity Read

Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia.Semantic proximity Read

Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation.Semantic proximity Read

Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaSemantic proximity Read

Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia.Semantic proximity Read

Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.Semantic proximity Read

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.Semantic proximity Read